Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(8):1041–1045. doi: 10.1038/bjc.1997.505

Vascular endothelial growth factor and lymph node metastasis in primary lung cancer.

Y Ohta 1, Y Watanabe 1, S Murakami 1, M Oda 1, Y Hayashi 1, A Nonomura 1, Y Endo 1, T Sasaki 1
PMCID: PMC2228101  PMID: 9376264

Abstract

The relationship between vascular endothelial growth factor (VEGF) and lymph node metastasis was studied in 90 cases of primary lung cancer without distant metastasis. As a result of quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis, the VEGF121 mRNA expression levels in lung cancer tissues with nodal metastasis (n = 35) were higher than in those without nodal metastasis (n = 55). However, no significant difference could be found in VEGF121 mRNA expression levels as stratified by tumour size (T1N0M0 vs T2N0M0). Simultaneously, ten lymph nodes (four node positive and six node negative) together with the corresponding primary lung tumours and adjacent normal lung tissue, were studied for VEGF expression. The VEGF mRNA expression in metastatic lymph nodes was intense in three out of the four cases examined. Further, while VEGF expression levels in metastatic lymph nodes were conspicuously higher than those for the primary site, all its expression levels in non-metastatic nodes were inferior to those of the primary tumours. Except for macrophages, the VEGF antigen was identified mainly in the cytoplasm of metastatic cancer cells and the endothelial cells of blood or lymphatic vessels in lymph nodes. Although the detailed mechanisms and the significance of strong VEGF expressions in metastatic lymph nodes are still unknown, these data are consistent with a model whereby VEGF increases the opportunity for nodal metastasis through neoblood and lymphatic vessels.

Full text

PDF
1043

Images in this article

1043Figure 2
on p.1043
1043Figure 1
on p.1043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosari S., Lee A. K., DeLellis R. A., Wiley B. D., Heatley G. J., Silverman M. L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992 Jul;23(7):755–761. doi: 10.1016/0046-8177(92)90344-3. [DOI] [PubMed] [Google Scholar]
  2. Craft P. S., Harris A. L. Clinical prognostic significance of tumour angiogenesis. Ann Oncol. 1994 Apr;5(4):305–311. doi: 10.1093/oxfordjournals.annonc.a058829. [DOI] [PubMed] [Google Scholar]
  3. Gabrilovich D. I., Chen H. L., Girgis K. R., Cunningham H. T., Meny G. M., Nadaf S., Kavanaugh D., Carbone D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. 1996 Oct;2(10):1096–1103. doi: 10.1038/nm1096-1096. [DOI] [PubMed] [Google Scholar]
  4. Guidi A. J., Fischer L., Harris J. R., Schnitt S. J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst. 1994 Apr 20;86(8):614–619. doi: 10.1093/jnci/86.8.614. [DOI] [PubMed] [Google Scholar]
  5. Macchiarini P., Fontanini G., Hardin M. J., Squartini F., Angeletti C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 1992 Jul 18;340(8812):145–146. doi: 10.1016/0140-6736(92)93217-b. [DOI] [PubMed] [Google Scholar]
  6. Noguchi S., Aihara T., Motomura K., Inaji H., Imaoka S., Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol. 1996 Feb;148(2):649–656. [PMC free article] [PubMed] [Google Scholar]
  7. Ohta Y., Endo Y., Tanaka M., Shimizu J., Oda M., Hayashi Y., Watanabe Y., Sasaki T. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res. 1996 Aug;2(8):1411–1416. [PubMed] [Google Scholar]
  8. Ohta Y., Watanabe Y., Tabata T., Oda M., Hayashi Y., Endo Y., Tanaka M., Sasaki T. Inhibition of lymph node metastasis by an anti-angiogenic agent, TNP-470. Br J Cancer. 1997;75(4):512–515. doi: 10.1038/bjc.1997.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stasiak P. C., Lane E. B. Sequence of cDNA coding for human keratin 19. Nucleic Acids Res. 1987 Dec 10;15(23):10058–10058. doi: 10.1093/nar/15.23.10058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., Abraham J. A. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991 Jun 25;266(18):11947–11954. [PubMed] [Google Scholar]
  11. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E. N., Moore D. H., Meli S., Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992 Dec 16;84(24):1875–1887. doi: 10.1093/jnci/84.24.1875. [DOI] [PubMed] [Google Scholar]
  12. Yamazaki K., Abe S., Takekawa H., Sukoh N., Watanabe N., Ogura S., Nakajima I., Isobe H., Inoue K., Kawakami Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 1994 Oct 15;74(8):2245–2250. doi: 10.1002/1097-0142(19941015)74:8<2245::aid-cncr2820740807>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES